Prof. Xiaolei Wang | Biomedical | Best Researcher Award

Prof Xiaolei Wang, Nanchang University, China

Professor Xiaolei Wang is a distinguished researcher at Nanchang University, specializing in photo-responsive materials for biomedical applications. Holding a Ph.D. from the Changchun Institute of Applied Chemistry (2009) under Academician Yang Xiurong, he is recognized as a National Talent and a Changjiang Young Scholar. He serves as Dean of Jiluan College and Deputy Director of the National-Local Joint Center for Bioengineering Drugs and Technologies. With over 130 publications in top-tier journals like Advanced Materials and ACS Nano, 42 patents, and multiple prestigious awards, his groundbreaking research bridges academia and industry, driving impactful innovations in nanomedicine. 🚀

Professional Profile:

Scopus

Suitability for Best Researcher Award

Professor Xiaolei Wang is a highly accomplished researcher in photo-responsive materials for biomedical applications. His extensive contributions to nanomedicine, regenerative medicine, and antimicrobial technologies demonstrate a profound impact on both academic research and industry. With 130+ high-impact publications, 42 patents, and leadership roles in prestigious institutions, he has consistently driven innovation and interdisciplinary collaboration. His recognition as a National Talent and Changjiang Young Scholar further cements his influence in the scientific community.

Education & Experience 🎓👨‍🏫

🎓 Ph.D. in Applied Chemistry (2009) – Changchun Institute of Applied Chemistry, under Academician Yang Xiurong
📚 Dean, Jiluan College – Nanchang University
🏥 Deputy Director – National-Local Joint Center for Bioengineering Drugs and Technologies
👨‍🔬 Professor – Nanchang University
📖 Research Collaborator – Chinese PLA General Hospital, First Affiliated Hospital of Nanchang University, and Institute of Biomedical Innovation

Professional Development 🚀

Professor Xiaolei Wang has made pioneering contributions to biomedical applications of photo-responsive materials, leading 16 major research projects and publishing 161 SCI-indexed papers. His collaborative projects with top research institutions focus on advanced wound healing, Helicobacter pylori treatment, and neurobiological enhancements. As a recognized National Talent and Changjiang Young Scholar, he bridges cutting-edge research with industry applications, collaborating with China National Pharmaceutical Group and Guangyuan Group. His work in zinc oxide research has transformed its optical properties for biomedical use, earning accolades like the China Hi-Tech Fair Outstanding Product Award. His innovations continue to drive impactful scientific advancements. 🌟

Research Focus 🔬

Professor Xiaolei Wang’s research revolves around photo-responsive materials in biomedicine, particularly in wound healing, antibacterial therapy, and neurological treatments. His breakthrough studies on light-activated artificial skin have set new standards in regenerative medicine. His work on metal-organic framework-based hydrogen-release platforms for targeted bacterial infections is a pioneering approach in antimicrobial nanotechnology. His photo- and magnetic-responsive nasal delivery systems for mental health treatments are redefining non-invasive therapeutic strategies. With a strong interdisciplinary approach, his research integrates materials science, nanotechnology, and medicine, shaping the future of next-generation biomedical treatments. 🧬✨

Awards & Honors 🏅

🏆 National Hundred, Thousand, and Ten Thousand Talents Project – Recognized as a National Talent
🏅 Changjiang Young Scholar Award – Prestigious academic honor
🏆 First Prize of Natural Science (2012) – Jilin Province
🏅 First Prize of Medical Technology (2021) – Jiangxi Province
🏆 China Hi-Tech Fair Outstanding Product Award – Recognition for innovation
🏅 2024 Outstanding Paper Award – Advanced Sensor and Energy Materials
🏆 42 Patents – Innovations in nanomedicine and materials science

Publication Top Notes:

🦷 Yellow light and ultrasound dual-responsive strontium-doped zinc oxide composites for dental caries prevention and remineralization
🍺 Cold beer-inspired multifunctional nanozyme for ischemic stroke with rapid thrombus clearance and long-lasting hydrogen therapy
🩹 A molybdenum sulfide-based nitric oxide controlled release oral gel for rapid healing of oral mucosal ulcers
🦴 Time-dependent electrical active and ultrasound-responsive calcium titanate implant coating with immunomodulation, osteogenesis, and customized antibacterial activity
🦾 Inflammatory microenvironment regulation and osteogenesis promotion by bone-targeting calcium and magnesium repletion nanoplatform for osteoporosis therapy – 📑 1 citation

Assist. Prof. Dr. Mohamed skiba, University of rouen, France

Dr. Mohamed Skiba, is a French national and a distinguished pharmaceutical scientist. He is a lecturer at the Faculty of Medicine and Pharmacy in Rouen, where he leads the Pharmaceutical Team within the Galenic Group. Dr. Skiba earned his Ph.D. in Pharmaceutical Sciences from the University of Paris XI in 1994 and has been active in pharmaceutical research since 1990, focusing on cyclodextrin and drug vectorization. With over 140 international publications, 80 patents, and numerous contributions to books and congresses, he is a recognized expert in pharmaceutical technology. Dr. Skiba is also an active member of several scientific societies, including the French Society of Chemistry and the French Association of Teachers of Technological Pharmacy. He is fluent in French, English, and Arabic.

Professional Profile:

Orcid

Suitability for Best Innovation Award: Dr. Mohamed SKIBA

Dr. Mohamed Skiba’s extensive work in pharmaceutical sciences, particularly his research in drug formulation and cyclodextrin technologies, positions him as a strong candidate for the Best Innovation Award. His innovations, reflected in his numerous patents and publications, highlight his ability to drive pharmaceutical advancements with real-world applications. His leadership in academic and research institutions further amplifies his impact, making him a deserving recipient of this prestigious award.

🎓Education:

Dr. Mohamed Skiba holds a Ph.D. in Pharmaceutical Sciences, which he earned in 1994 from the University of Paris XI, Southern Paris. His academic journey also includes a Diploma of Thorough Studies in Pharmacotechnology and Biopharmacy (1990) from the University of Paris XI in Châtenay-Malabry. In 1990, he obtained a Diploma in Veterinary Pharmaceuticals from the Faculty of Pharmacy, University of Clermont-Ferrand I. Additionally, Dr. Skiba completed advanced studies in pharmacology and electrophysiology with a Control of Research degree from the University of Poitiers in 1989. He also pursued studies in patent rights at the Faculty of Orsay, University of Paris-South, enriching his expertise in pharmaceutical and intellectual property matters.

🏢Work Experience:

Dr. Mohamed Skiba has been a lecturer at the Faculty of Medicine and Pharmacy, University of Rouen, France, since 1998. In this role, he teaches courses in galenic and industrial galenic pharmacy to both undergraduate and graduate students, while also leading the Pharmaceutical Team within the Galenic Group. His professional experience includes serving as a trainee at the Central Pharmacy of the Hospitals of Paris (PCH) and working as an Associated Attaché in Toxicology and Clinical Pharmacology at the Hospital of Corbeil-Essonnes, further enhancing his expertise in pharmaceutical technology and clinical applications.

🏅Awards & Recognition:

Dr. Mohamed Skiba is a prolific contributor to the field of pharmaceutical technology, holding over 80 patents that highlight his innovative work. He has authored 140 international publications and contributed to 9 book chapters, making significant scholarly impacts. Additionally, Dr. Skiba has presented 71 communications at prestigious scientific congresses, sharing his research and advancements with the global scientific community.

🔬Research Focus:

Dr. Skiba’s research primarily centers on pharmaceutical technology, with a particular focus on cyclodextrin and drug vectorization. His work involves improving drug delivery systems, studying bio-polymeric materials, and developing innovative pharmaceutical formulations. He has been involved in numerous pharmaceutical research projects since 1990, contributing to the advancement of drug delivery and formulation technologies.

Publication Top Notes:

Powder Self-Emulsifying Drug Delivery System for Mitotane: In Vitro and In Vivo Evaluation
In vitro dissolution of encapsulated or dispersed vitamin E and cholesterol is correlated with preservation of refrigerated ovine sperm
Exploring the Therapeutic Potential of Algerian Propolis: GC/MS Profiling, Protective Inclusion Complex, and In Silico Evaluation Against SARS‐CoV‐2 Main Proteases
Development of a Novel Cyclodextrin–Chitosan Polymer for an Efficient Removal of Pharmaceutical Contaminants in Aqueous Solution